Dis­trict court hands Janssen a win in patent feud with Vi­a­tris

John­son & John­son’s Janssen has a new court win re­lat­ed to its an­tipsy­chot­ic drug.

A judge on Mon­day ruled that My­lan’s pro­posed la­bels for a gener­ic ver­sion of paliperi­done, Janssen’s an­tipsy­chot­ic drug, would in­fringe on one of Janssen’s patents, per an opin­ion and or­der filed in New Jer­sey Dis­trict Court. (My­lan merged with Pfiz­er’s Up­john unit in a deal that closed in late 2020 and is now called Vi­a­tris.)

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.